Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.Barrons • 04/16/26
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact SciencesPRNewsWire • 04/16/26
Unlocking Q1 Potential of Abbott (ABT): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 04/13/26
Jury orders Abbott to pay $53 million in preterm infant formula trial, media report saysReuters • 04/10/26
Abbott (ABT) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 04/09/26
New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their healthPRNewsWire • 04/09/26
Abbott Laboratories: A Dividend Aristocrat With A Compelling Valuation And Return PotentialSeeking Alpha • 04/09/26
Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth KnowingZacks Investment Research • 04/08/26
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?Zacks Investment Research • 04/08/26
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending StockZacks Investment Research • 04/01/26
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platformPRNewsWire • 03/30/26
John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screeningPRNewsWire • 03/24/26